PTHrP-induced hypercalcemia in paragangliomas: Tumor dedifferentiation as sign of bad prognosis
Endocrinol Diabetes Nutr (Engl Ed)
.
2022 Jan;69(1):73-75.
doi: 10.1016/j.endien.2022.01.004.
Authors
Maria D Alcantara-Laguna
1
,
Yiraldine Herrera-Martínez
2
,
Marina E Sánchez-Frías
3
,
Maria A Gálvez-Moreno
4
,
Aura D Herrera-Martínez
5
Affiliations
1
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain.
2
Nuclear Medicine Service, Virgen del Rocio University Hospital, Seville, Spain.
3
Pathology Service, Reina Sofia University Hospital, Córdoba, Spain.
4
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain. Electronic address: mariaa.galvez.sspa@juntadeandalucia.es.
5
Endocrinology and Nutrition Service, Reina Sofia University Hospital, Córdoba, Spain. Electronic address: aurita.dhm@gmail.com.
PMID:
35232563
DOI:
10.1016/j.endien.2022.01.004
No abstract available
Publication types
Case Reports
MeSH terms
Humans
Hypercalcemia* / etiology
Paraganglioma* / complications
Paraganglioma* / diagnosis
Parathyroid Hormone-Related Protein
Prognosis
Substances
Parathyroid Hormone-Related Protein